Learn about nyse:ABBV with our data and independent analysis including share price, star rating, valuation, dividends, and financials.

Glenmark Pharmaceuticals shares rallied 10% on Friday to reach a record high after its biotech subsidiary signed a ...

This was the stock's third consecutive day of gains.

AbbVie Inc. (NYSE: ABBV) is one of the undervalued S&P 500 stocks to buy according to hedge funds. On June 25, the “Elahere Market Opportunities and Strategies to 2034” report was added to ...

Shares of AbbVie Inc. ABBV slipped 2.40% to $182.31 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.52% to 6,173.07 ...

Recently, Zacks.com users have been paying close attention to AbbVie (ABBV). This makes it worthwhile to examine what the stock has in store.

View the latest AbbVie Inc. (ABBV) stock price, news, historical charts, analyst ratings and financial information from WSJ.

AbbVie Inc. (NYSE:ABBV) is one of the best dividend stocks for a bear market. The company holds the title of a Dividend King, having raised its dividend for 52 straight years. That kind of track ...

NORTH CHICAGO - AbbVie Inc. (NYSE: ABBV), a pharmaceutical giant with a market capitalization of $327.65 billion, announced Friday that its board of directors has declared a quarterly cash dividend of ...

TEMPLE, a Phase 3 multicenter, randomized, double-blind, head-to-head study, evaluated the tolerability, safety and efficacy of atogepant compared to topiramate for the preventive treatment of ...